Fig. 8
From: Identification of an alternative splicing signature as an independent factor in colon cancer
The clinical relevance of the signature in the entire cohort. a-d Relationship between the Percent Spliced In (PSI) value of GMPPA-57710-RI and other clinical variables, including the pathological stage, the M category, the N category, and the T category. e Relationship between the PSI of NRG4–31911-AT and the pathological stage. f-h Relationship between the PSI value of PDCD4–13086-ES and other clinical variables, including the pathological stage, the M category, and the N category. i Relationship between the risk score of the signature and the T category